Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach

P. N. R. Dekhuijzen (Corresponding Author), W. Vincken, J. C. Virchow, N. Roche, A. Agusti, F. Lavorini, W. M. Van Aalderen, D. Price

Research output: Contribution to journalReview article

51 Citations (Scopus)
4 Downloads (Pure)

Abstract

Inhaled medication is the cornerstone of the pharmacological treatment of patients with asthma and COPD. The major two classes of inhaled medication include corticosteroids (ICS) and bronchodilators. There is a wide diversity in molecules in both classes. Moreover, there is a wide variation in delivery systems. The correct use of inhalers is not granted and patients often incur in many mistakes when using pMDIs and DPIs, despite repeated instructions. A better matching between patient and device could be accomplished if the physician is aware of: (1) the patient characteristics (disease, severity, fluctuation in airflow obstruction, etc); (2) what class of medication is indicated; (3) where in the lung the medication should be delivered; and, (4) how this can be best achieved by a given device in this specific patient. We focus on the prescription of pMDIs and DPIs at the GP office or at the outpatient clinic of the hospital, and we propose an evidence based approach enabling the caregiver to make a rational choice in only a few minutes by just considering the following four simple questions: Who?, What? Where? and How? (the so-called 3W-H approach).

Original languageEnglish
Pages (from-to)1817-1821
Number of pages5
JournalRespiratory Medicine
Volume107
Issue number12
Early online date25 Sep 2013
DOIs
Publication statusPublished - 1 Dec 2013

Fingerprint

Nebulizers and Vaporizers
Chronic Obstructive Pulmonary Disease
Prescriptions
Asthma
Hospital Outpatient Clinics
Equipment and Supplies
Bronchodilator Agents
Caregivers
Adrenal Cortex Hormones
Pharmacology
Physicians
Lung

Keywords

  • Asthma
  • COPD
  • DPI's
  • Inhaled medication
  • pMDI's

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Dekhuijzen, P. N. R., Vincken, W., Virchow, J. C., Roche, N., Agusti, A., Lavorini, F., ... Price, D. (2013). Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach. Respiratory Medicine, 107(12), 1817-1821. https://doi.org/10.1016/j.rmed.2013.09.013

Prescription of inhalers in asthma and COPD : Towards a rational, rapid and effective approach. / Dekhuijzen, P. N. R. (Corresponding Author); Vincken, W.; Virchow, J. C.; Roche, N.; Agusti, A.; Lavorini, F.; Van Aalderen, W. M.; Price, D.

In: Respiratory Medicine, Vol. 107, No. 12, 01.12.2013, p. 1817-1821.

Research output: Contribution to journalReview article

Dekhuijzen, PNR, Vincken, W, Virchow, JC, Roche, N, Agusti, A, Lavorini, F, Van Aalderen, WM & Price, D 2013, 'Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach', Respiratory Medicine, vol. 107, no. 12, pp. 1817-1821. https://doi.org/10.1016/j.rmed.2013.09.013
Dekhuijzen PNR, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F et al. Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach. Respiratory Medicine. 2013 Dec 1;107(12):1817-1821. https://doi.org/10.1016/j.rmed.2013.09.013
Dekhuijzen, P. N. R. ; Vincken, W. ; Virchow, J. C. ; Roche, N. ; Agusti, A. ; Lavorini, F. ; Van Aalderen, W. M. ; Price, D. / Prescription of inhalers in asthma and COPD : Towards a rational, rapid and effective approach. In: Respiratory Medicine. 2013 ; Vol. 107, No. 12. pp. 1817-1821.
@article{223e7a7e3da441e5b60d65325630dabf,
title = "Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach",
abstract = "Inhaled medication is the cornerstone of the pharmacological treatment of patients with asthma and COPD. The major two classes of inhaled medication include corticosteroids (ICS) and bronchodilators. There is a wide diversity in molecules in both classes. Moreover, there is a wide variation in delivery systems. The correct use of inhalers is not granted and patients often incur in many mistakes when using pMDIs and DPIs, despite repeated instructions. A better matching between patient and device could be accomplished if the physician is aware of: (1) the patient characteristics (disease, severity, fluctuation in airflow obstruction, etc); (2) what class of medication is indicated; (3) where in the lung the medication should be delivered; and, (4) how this can be best achieved by a given device in this specific patient. We focus on the prescription of pMDIs and DPIs at the GP office or at the outpatient clinic of the hospital, and we propose an evidence based approach enabling the caregiver to make a rational choice in only a few minutes by just considering the following four simple questions: Who?, What? Where? and How? (the so-called 3W-H approach).",
keywords = "Asthma, COPD, DPI's, Inhaled medication, pMDI's",
author = "Dekhuijzen, {P. N. R.} and W. Vincken and Virchow, {J. C.} and N. Roche and A. Agusti and F. Lavorini and {Van Aalderen}, {W. M.} and D. Price",
year = "2013",
month = "12",
day = "1",
doi = "10.1016/j.rmed.2013.09.013",
language = "English",
volume = "107",
pages = "1817--1821",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Prescription of inhalers in asthma and COPD

T2 - Towards a rational, rapid and effective approach

AU - Dekhuijzen, P. N. R.

AU - Vincken, W.

AU - Virchow, J. C.

AU - Roche, N.

AU - Agusti, A.

AU - Lavorini, F.

AU - Van Aalderen, W. M.

AU - Price, D.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Inhaled medication is the cornerstone of the pharmacological treatment of patients with asthma and COPD. The major two classes of inhaled medication include corticosteroids (ICS) and bronchodilators. There is a wide diversity in molecules in both classes. Moreover, there is a wide variation in delivery systems. The correct use of inhalers is not granted and patients often incur in many mistakes when using pMDIs and DPIs, despite repeated instructions. A better matching between patient and device could be accomplished if the physician is aware of: (1) the patient characteristics (disease, severity, fluctuation in airflow obstruction, etc); (2) what class of medication is indicated; (3) where in the lung the medication should be delivered; and, (4) how this can be best achieved by a given device in this specific patient. We focus on the prescription of pMDIs and DPIs at the GP office or at the outpatient clinic of the hospital, and we propose an evidence based approach enabling the caregiver to make a rational choice in only a few minutes by just considering the following four simple questions: Who?, What? Where? and How? (the so-called 3W-H approach).

AB - Inhaled medication is the cornerstone of the pharmacological treatment of patients with asthma and COPD. The major two classes of inhaled medication include corticosteroids (ICS) and bronchodilators. There is a wide diversity in molecules in both classes. Moreover, there is a wide variation in delivery systems. The correct use of inhalers is not granted and patients often incur in many mistakes when using pMDIs and DPIs, despite repeated instructions. A better matching between patient and device could be accomplished if the physician is aware of: (1) the patient characteristics (disease, severity, fluctuation in airflow obstruction, etc); (2) what class of medication is indicated; (3) where in the lung the medication should be delivered; and, (4) how this can be best achieved by a given device in this specific patient. We focus on the prescription of pMDIs and DPIs at the GP office or at the outpatient clinic of the hospital, and we propose an evidence based approach enabling the caregiver to make a rational choice in only a few minutes by just considering the following four simple questions: Who?, What? Where? and How? (the so-called 3W-H approach).

KW - Asthma

KW - COPD

KW - DPI's

KW - Inhaled medication

KW - pMDI's

UR - http://www.scopus.com/inward/record.url?scp=84890309403&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2013.09.013

DO - 10.1016/j.rmed.2013.09.013

M3 - Review article

C2 - 24120398

AN - SCOPUS:84890309403

VL - 107

SP - 1817

EP - 1821

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 12

ER -